Multi-Center Randomized Control Trial to Study the Effectiveness of Hyperbaric Oxygen for COVID-19 Patients with Moderate to Severe Respiratory Distress

Brief description of study

The purpose of this study is to investigate whether hyperbaric oxygen therapy is an effective way to treat hypoxemia (low blood oxygen levels) in patients who have tested positive for COVID-19 or have a clear clinical diagnosis of COVID-19 and have high supplemental oxygen requirements. In this study, all patients will receive the usual standard care to treat hypoxemia. Some patients will receive the study’s hyperbaric oxygen therapy in addition to standard of care.


Clinical Study Identifier: s20-00897
ClinicalTrials.gov Identifier: NCT04619719
Principal Investigator: David C Lee.


If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.